...
首页> 外文期刊>Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology >Postmastectomy intensity modulated radiation therapy following immediate expander-implant reconstruction.
【24h】

Postmastectomy intensity modulated radiation therapy following immediate expander-implant reconstruction.

机译:立即扩张器-植入物重建后的乳房切除术后强度调节放射治疗。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND/PURPOSE: To evaluate radiation plans of patients undergoing mastectomy with immediate expander-implant reconstruction followed by postmastectomy radiation therapy (PMRT). MATERIALS/METHODS: We identified 41 patients from June 2004 to May 2007 who underwent mastectomy, immediate expander-implant reconstruction, and PMRT with intensity-modulated radiation therapy. We assessed chest wall (CW) coverage and volume of heart and lung irradiated. RESULTS: In 73% of patients, all CW borders were adequately covered, and in 22%, all but 1 border were adequately covered. The total lung V(20) was<20% in 39/41 patients. The mean lung V(20) was 13% (range, 3-23%), and the mean heart D(mean) was 2.81 Gy (range, 0.53-9.60 Gy). In patients with left-sided lesions without internal mammary nodes (IMNs) treatment (n=22), the mean lung V(20) was 12.6% and the mean heart D(mean) was 3.90 Gy, and in the patient with IMN treatment, the lung V(20) was 18% and heart D(mean) was 8.04 Gy. For right-sided lesions without IMN treatment (n=12), the mean lung V(20) was 12.4% and the mean heart D(mean) was 0.90 Gy, and in patients with IMN treatment (n=6), these numbers were 17.8% and 1.76 Gy. At a median follow-up of 29 months, the 30-month actuarial local control was 97%. CONCLUSIONS: In women undergoing immediate expander-implant reconstruction, PMRT can achieve excellent local control with acceptable heart and lung doses. These results can be achieved even when the IMN are being treated, although doses to the heart and lungs will be higher.
机译:背景/目的:评估乳腺切除术患者的放疗计划,并立即进行扩张器-植入物重建,然后进行乳房切除术后放疗(PMRT)。材料/方法:我们确定了2004年6月至2007年5月期间接受乳房切除术,即刻扩张器-植入物重建以及采用强度调制放射治疗的PMRT的41例患者。我们评估了胸壁(CW)的覆盖范围以及受辐照的心脏和肺部的体积。结果:在73%的患者中,所有CW边界均被充分覆盖,而在22%的患者中,除1个边界之外的所有边界均被充分覆盖。 39/41例患者的总肺V(20)<20%。平均肺V(20)为13%(范围3-23%),平均心脏D(平均值)为2.81 Gy(范围0.53-9.60 Gy)。在没有内部乳腺淋巴结(IMN)治疗的左侧病变患者中(n = 22),接受IMN治疗的患者的平均肺V(20)为12.6%,平均心脏D(平均值)为3.90 Gy。 ,肺部V(20)为18%,心脏D(平均值)为8.04 Gy。对于未经IMN治疗的右侧病变(n = 12),平均肺V(20)为12.4%,平均心脏D(平均值)为0.90 Gy,在接受IMN治疗的患者(n = 6)中,这些数字分别为17.8%和1.76 Gy。在29个月的中位随访中,30个月的精算本地控制率为97%。结论:在接受立即扩张-种植体重建的女性中,PMRT可以在可接受的心脏和肺部剂量的情况下实现出色的局部控制。即使对IMN进行治疗,也可以获得这些结果,尽管对心脏和肺部的剂量会更高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号